B
Bellerophon Therapeutics Inc
F:6L7A
Bellerophon Therapeutics Inc
F:6L7A
Price:
0.35
EUR
Market Cap:
€3.7m
Relative Value
There is not enough data to reliably calculate the relative value of 6L7A.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
6L7A
Relative Value
Base Case
Not Available
Multiples Across Competitors
6L7A Competitors Multiples
Bellerophon Therapeutics Inc Competitors
Bellerophon Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bellerophon Therapeutics Inc
F:6L7A
|
3.7m EUR | 0.8 | -0.5 | 0 | 0 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD | 4.6 | 31 | 17.7 | 24.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD | 17.7 | 62.5 | 47.5 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD | 5.9 | 45.6 | 23 | 27.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD | 3.5 | 27.1 | 14.7 | 21.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD | 5.7 | 39.2 | 22.9 | 30.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.4B EUR | 2 | 22 | 12.1 | 17.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD | 12.2 | 49.6 | 35.2 | 39 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD | 2.3 | 28.6 | 11 | 18.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD | 8.3 | 46.8 | 25.8 | 28.3 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
